119th Congress · HOUSE BILLBILL

H.R. 8857 — Next GEN Act of 2026

“To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.”

Introduced May 15, 2026

Last action May 15, 2026

Pipeline · Bill → Law

Step 1

Introduced

May 15, 2026

Step 2

Referred

May 15, 2026

E&C · Ways & Means

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 2 actions

May 15, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 15, 2026

Introduced in House